“Delivered” Is Not the Same as “Ready”
A milestone date in a financing plan can hide several different commitments. Before it goes into the deck, find out what will actually be usable on that day.
Read the essay ↗NarraFlect Insights
A point of view on how science becomes a decision.
Scientific rigor is not the same as decision usefulness.
Latest insights
When One Result Leads to Conflicting Judgments
How to identify what experts disagree about, choose the right next review, and preserve objections that still matter.
Read the insight ↗
What a Partner Needs to Know Before Asking for More
How to give a prospective biotech partner enough context, evidence, and uncertainty to judge whether the next review is worth undertaking.
Read the insight ↗
The Milestone Was Real. The Decision Was Still Open
Before funding a biotech milestone, ask whether different results could change the next action. Two firsthand examples show how to keep that choice open without undervaluing the work.
Read the insight ↗
Why Good Science Still Fails to Drive Decisions in Biotech
The quality of the science is rarely the problem. More often, the problem is whether the evidence has been organized around the decision someone actually needs to make.
Read the insight ↗Useful enough to support a decision.
Every article is designed to clarify a real communication choice, not to repeat generic presentation advice.
- 01
Firsthand context
Frameworks begin with cross-functional biotech work and the communication friction that appears between disciplines.
- 02
Clear boundaries
Examples are anonymized, confidential information is excluded, and illustrative situations are labeled.
- 03
Decision utility
Each piece should leave the reader with a sharper question, a usable distinction, or a practical next step.